For differentiating TB disease from other respiratory diseases, the most optimal biosignature was a three-marker serodiagnostic model comprising anti-TB-LTBI IgG, anti-Tpx IgG and anti-MPT64 IgA. Here, CD79A is linked to respiratory system disorder.